Page last updated: 2024-12-05

allyl isothiocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

allyl isothiocyanate: used in the manufacture of flavors, war gases; medical use as a counterirritant; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

allyl isothiocyanate : An isothiocyanate with the formula CH2=CHCH2N=C=S. A colorless oil with boiling point 152degreeC, it is responsible for the pungent taste of mustard, horseradish, and wasabi. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5971
CHEMBL ID233248
CHEBI ID73224
MeSH IDM0045540

Synonyms (114)

Synonym
gtpl2420
2-propenyl isothiocyanate
allyl isothiocyanate
senf oel
isothiocyanic acid, allyl ester
allyl isosulfocyanate
allylsenfoel
oleum sinapis volatile
oleum sinapis
nsc5572
nci-c50464
allyl isothiocyanate, non-perfume grade
isothiocyanate d'allyle
aitc
wln: scn2u1
potassium allyl isothiocyanate
potassium, (1-isothiocyanato-2-propenyl)-
allylsevenolum
1-propene, 3-isothiocyanato-
redskin
57-06-7
nsc-5572
allylsenevol
propene, 3-isothiocyanato-
senfoel
D02818
allyl isothiocyanate (usp)
ccris 20
isothiocyansaeureallylester
fema number 2034
allyl sevenolum
nsc 5572
3-isothiocyanato-1-propene
allyspol
carbospol
epa pesticide chemical code 004901
allyl isosulphocyanate
isothiocyanic acid allyl ester
allyl isothiocyanate [usan]
einecs 200-309-2
allyspol 75ec
un1545
hsdb 617
allylsenfoel [german]
allylisothiokyanat [czech]
brn 0773748
caswell no. 027
isothiocyanate d'allyle [french]
ai3-15283
fema no. 2034
allyl thioisocyanate
allyl isothiocyanate (natural)
senf oel [german]
isothiocyanic acid,allyl ester
3-isothiocyanatoprop-1-ene
inchi=1/c4h5ns/c1-2-3-5-4-6/h2h,1,3h
NCGC00091743-01
allyl isothiocyanate, >=95%, fcc
allyl isothiocyanate, contains bht as stabilizer, 95%
8007-40-7
chebi:73224 ,
CHEMBL233248 ,
allyl isothiocyanate, stabilized
allylisothiocyanate
bdbm50203072
I0185
AKOS000119301
NCGC00091743-02
HMS3264D06
3-isothiocyanato-prop-1-ene
C19317
dtxcid8047
NCGC00256536-01
cas-57-06-7
dtxsid3020047 ,
tox21_302890
NCGC00259798-01
tox21_202249
nsc-760137
pharmakon1600-01506103
nsc760137
tox21_111165
allyl isothiocyanate, stabilized (0.1% tocopherols)
allylisothiokyanat
bn34fx42g3 ,
allyl isothiocyanate [usan:usp]
allyl isothiocyanate, stabilized [un1545] [poison]
unii-bn34fx42g3
BP-12926
allyl isothiocyanate [who-dd]
allyl isothiocyanate [usp monograph]
allyl isothiocyanate [fcc]
allyl isothiocyanate [fhfi]
allyl isothiocyanate [hsdb]
allyl isothiocyanate [mart.]
allyl isothiocyanate [iarc]
allyl isothiocyanate [mi]
CCG-213613
3-iso-thiocyanatoprop-1-ene
AB01563144_01
F9995-1653
mfcd00004822
J-512735
allyl isothiocyanate, 97%
allyl isothiocyanate, purum, >=98% (gc)
allyl isothiocyanate, pestanal(r), analytical standard, stabilized
allyl isothiocyanate non-perfume grade
Q419406
3-isothiocyanato-propene
STL194262
allyl isothiocyanate 100 microg/ml in acetonitrile
EN300-19008
Z104472178
fats and glyceridicoils, mustard

Research Excerpts

Overview

Allyl isothiocyanate (AITC) is a soil biofumigant used for controlling soil-borne pests that reduce the growth, quality, and yield of food crops. mitochondrial dysfunction has been proposed to play a crucial role in its lethal mechanisms.

ExcerptReferenceRelevance
"Allyl isothiocyanate (AITC) is a natural antioxidant and anti-inflammatory agent."( Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity.
Matouk, AI; Waz, S, 2022
)
1.74
"Allyl isothiocyanate (AITC) is a promising alternative to chemical fumigants, and mitochondrial dysfunction has been proposed to play a crucial role in its lethal mechanisms; however, the specific lethal mechanisms of AITC remain unknown. "( Function of four mitochondrial genes in fumigation lethal mechanisms of Allyl Isothiocyanate against Sitophilus zeamais adults.
Jiang, Y; Ma, Z; Sun, Y; Wu, H; Xu, N; Zhang, C, 2021
)
2.3
"Allyl isothiocyanate (AITC) is a soil fumigant that protects plants against soil-borne pathogens, weeds and insects when present in the root-zone. "( Effects of fertilizers and soil amendments on the degradation rate of allyl isothiocyanate in two typical soils of China.
Cao, A; Chen, X; Fang, W; Li, Y; Liu, J; Tang, X; Wang, Q; Yan, D; Zhang, Y, 2022
)
2.4
"Allyl isothiocyanate (AITC) is a soil biofumigant used for controlling soil-borne pests that reduce the growth, quality, and yield of food crops. "( Comparison of drip-irrigated or injected allyl isothiocyanate against key soil-borne pathogens and weeds.
Cao, A; Chen, X; Fang, W; Guo, A; Ji, Y; Li, Y; Song, Z; Wang, Q; Yan, D; Zhang, Y, 2023
)
2.62
"Allyl Isothiocyanate (AITC) is a natural isothiocyanate found in cruciferous plants with anti-inflammatory and antioxidant abilities."( Allyl isothiocyanate mitigates airway inflammation and constriction in a house dust mite-induced allergic asthma model via upregulation of tight junction proteins and the TRPA1 modulation.
Ali, M; Chen, HY; Chiang, YF; Hsia, SM; Huang, KC; Lai, YH, 2023
)
3.07
"Allyl isothiocyanate (AITC) is an excellent active phytoconstituent recently revealed for cancer treatment. "( Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting.
Patel, JK; Patil, PB, 2023
)
2.35
"Allyl isothiocyanate (AITC) is a main ingredient of traditional spice Wasabia japonica, which is reported to have anti-bacterial and antiparasitic activities."( Anti-Malarial Activity of Allyl Isothiocyanate and N-acetyl-S-(N-allylthiocarbamoyl)-l-Cysteine.
Hashimoto, T; Iwanaga, S; Kanazawa, K; Yoshioka, S, 2023
)
1.93
"Allyl isothiocyanate (AITC) is a natural product with high volatility that is used as a biofumigant to alleviate soil-borne plant diseases, and problems such as root knot nematodes (RKNs) that necessitate continuous cropping. "( Effects of allyl isothiocyanate fumigation on medicinal plant root knot disease control, plant survival, and the soil bacterial community.
Huang, H; Li, J; Li, Y; Liu, Y; Lu, D; Mei, X; Xia, Y; Xu, X; Yang, M; Zhang, Z; Zhu, S, 2023
)
2.74
"Allyl isothiocyanate (AITC) is a highly volatile organic compound that is a potential antibacterial agent against food spoilage bacteria. "( Allyl isothiocyanate encapsulated halloysite covered with polyacrylate as a potential antibacterial agent against food spoilage bacteria.
Maruthupandy, M; Seo, J, 2019
)
3.4
"Allyl isothiocyanate (AITC) is a soil fumigant derived from plants that can effectively control soil-borne diseases. "( Soil properties, presence of microorganisms, application dose, soil moisture and temperature influence the degradation rate of Allyl isothiocyanate in soil.
Cao, A; Fang, W; Han, D; Huang, B; Li, Y; Liu, J; Ouyang, C; Wang, Q; Wang, X; Yan, D; Zhang, Y, 2020
)
2.21
"Allyl isothiocyanate (AITC) is a volatile organic compound with a potent insecticidal activity to the stored-grain pest Sitophilus zeamais Motschulsky, which severely damages grain storage and container transport worldwide. "( Target verification of allyl isothiocyanate on the core subunits of cytochrome c oxidase in Sitophilus zeamais by RNAi.
Ma, Z; Pu, S; Ren, J; Wu, H; Zhang, D; Zhang, M, 2021
)
2.37
"Allyl isothiocyanate (AITC) is a wide-spectrum antimicrobial compound found in mustard seeds, produced when their tissues are disrupted. "( Release of allyl isothiocyanate from mustard seed meal powder.
Dai, R; Lim, LT, 2014
)
2.23
"Allyl isothiocyanate (AITC) is an essential oil with antimicrobial activity against Escherichia coli O157:H7. "( Role of the BaeSR two-component regulatory system in resistance of Escherichia coli O157:H7 to allyl isothiocyanate.
Cordeiro, RP; Doria, JH; Holley, RA; Krause, DO, 2014
)
2.06
"Allyl isothiocyanate (AITC) is a phytochemical found in cruciferous vegetables that has known chemopreventive and chemotherapeutic activities. "( Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitis.
Davaatseren, M; Hwang, JT; Kim, MS; Park, JH; Sung, MJ; Wang, S, 2014
)
3.29
"Allyl isothiocyanate (AITC), is a natural compound found in plants belonging to the family Cruciferae and has strong antimicrobial activity and a biocidal activity against plants parasites. "( Effect of allyl isothiocyanate against Anisakis larvae during the anchovy marinating process.
Beninati, C; Giarratana, F; Giuffrida, A; Muscolino, D; Panebianco, F; Ziino, G, 2015
)
2.26
"Allyl isothiocyanate (AIT) is a natural compound found to limit the survival of E."( Effect of free-SH containing compounds on allyl isothiocyanate antimicrobial activity against Escherichia coli O157:H7.
Beta, T; Holley, RA; Hosseinian, FS; Luciano, FB, 2008
)
1.33
"Allyl isothiocyanate (AITC) is a well-recognized antimicrobial agent but, application of AITC to food systems is limited due to its high volatility and strong odor. "( Effects of microencapsulated Allyl isothiocyanate (AITC) on the extension of the shelf-life of Kimchi.
Kim, WY; Ko, JA; Park, HJ, 2012
)
2.11
"Allyl isothiocyanate (AITC) is a dietary component with possible anticancer effects, though much information about AITC and cancer has been obtained from cell studies. "( Assessment of DNA damage and repair in adults consuming allyl isothiocyanate or Brassica vegetables.
Albaugh, GA; Charron, CS; Clevidence, BA; Kramer, MH; Milner, JA; Novotny, JA; Vinyard, BT, 2013
)
2.08
"Allyl isothiocyanate (AIT) is an effective inhibitor of various pathogens, but its use in the food industry is limited by its volatility and pungency. "( Inhibitory effects of microencapsulated allyl isothiocyanate (AIT) against Escherichia coli O157:H7 in refrigerated, nitrogen packed, finely chopped beef.
Buffo, RA; Chacon, PA; Holley, RA, 2006
)
2.04
"Allyl isothiocyanate is well known to be a principal pungent constituent of horseradish and an agonist for transient receptor potential (TRP) A1. "( Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats.
Matsuda, H; Nagatomo, A; Ochi, M; Yoshikawa, M, 2007
)
2.17
"Allyl isothiocyanate (AITC) is a constituent of cruciferous vegetables. "( Identification and quantification of the N-acetylcysteine conjugate of allyl isothiocyanate in human urine after ingestion of mustard.
Chung, FL; Foiles, P; Ho, CT; Jiao, D, 1994
)
1.96

Effects

Allyl isothiocyanate (AITC) has been shown to play an important role in the improved symptoms of chronic obstructive pulmonary disease(COPD) The role in COPD lipid metabolism disorder and the molecular mechanism remains unclear.

ExcerptReferenceRelevance
"Allyl isothiocyanate(AITC) has been shown to play an important role in the improved symptoms of chronic obstructive pulmonary disease(COPD) and the inhibition of inflammation, but the role in COPD lipid metabolism disorder and the molecular mechanism remains unclear. "( Effects of allyl isothiocyanate on the expression, function, and its mechanism of ABCA1 and ABCG1 in pulmonary of COPD rats.
Dai, TT; Han, ZL; Li, CH; Sun, NX; Tao, FL; Wang, CY; Wang, DL; Wang, MW; Zhao, YN; Zhu, WT, 2021
)
2.45
"Allyl isothiocyanate (AITC) has been found to present sources from consumed cruciferous vegetables. "( Allyl isothiocyanate inhibits cell metastasis through suppression of the MAPK pathways in epidermal growth factor‑stimulated HT29 human colorectal adenocarcinoma cells.
Chen, FA; Chen, IL; Chiang, JH; Kuo, DH; Lai, KC; Lu, CC; Tang, YJ; Yang, JS, 2014
)
3.29
"Allyl isothiocyanate (AITC) has been reported to exhibit antimetastatic activity, but the mechanism remains unclear. "( Allyl isothiocyanate influences cell adhesion, migration and metalloproteinase gene expression in SK-Hep1 cells.
Hwang, ES; Kim, GH, 2009
)
3.24

Actions

ExcerptReferenceRelevance
"Allyl isothiocyanate (AITC) can inhibit the proliferation and induce apoptosis in many cancer cells."( Allyl Isothiocyanate Inhibits the Proliferation of Renal Carcinoma Cell Line GRC-1 by Inducing an Imbalance Between Bcl2 and Bax.
Chang, K; Jiang, Z; Liu, X; Xiong, J, 2016
)
2.6

Treatment

Allyl isothiocyanate treatment enhanced cell viability and reduced intracellular reactive oxygen species (ROS) production in both nitrite- and nitrosamine-treated cells significantly. Treatment with allyl isothsine, cinnamaldehyde, or GSK1016790A caused an increase in ATP concentration in culture medium that was abolished by preincubation with TRP channel antagonists.

ExcerptReferenceRelevance
"Allyl isothiocyanate treatment enhanced cell viability and reduced intracellular reactive oxygen species (ROS) production in both nitrite- and nitrosamine-treated cells significantly."( Effect of allyl isothiocyanate (AITC) in both nitrite- and nitrosamine-induced cell death, production of reactive oxygen species, and DNA damage by the single-cell gel electrophoresis (SCGE): does it have any protective effect on HepG2 cells?
Baydar, T; Erkekoğlu, P,
)
1.26
"Treatment with allyl isothiocyanate, cinnamaldehyde, or GSK1016790A caused an increase in ATP concentration in culture medium that was abolished by preincubation with TRP channel antagonists."( TRPA1 and TRPV4 activation in human odontoblasts stimulates ATP release.
Di Silvio, L; Duggal, AK; Egbuniwe, O; Grant, AD; Grover, S; Mavroudis, A; Renton, T; Yazdi, M, 2014
)
0.74
"Treatment with allyl isothiocyanate (AITC, a TRPA1 agonist) retarded the progression of atherosclerosis in apoE(-/-) mice but not apoE(-/-)TRPA1(-/-) mice."( Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.
Kou, YR; Lee, TS; Lu, TM; Shyue, SK; Zhao, JF, 2016
)
0.77

Toxicity

ExcerptReferenceRelevance
" Both types of conjugates caused considerable toxicity: allyl isothiocyanate conjugates gave effects comparable to the parent compound, but benzyl isothiocyanate was more toxic than its conjugates."( Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate.
Bruggeman, IM; Temmink, JH; van Bladeren, PJ, 1986
)
0.52
" To elucidate direct toxic effects of isothiocyanates (ITCs), BITC, AITC, or BITC-metabolites conjugated either with glutathione, cysteinylglycine, cysteine, or mercapturic acid were intravesically instilled into female F344 rats."( Toxic effects of benzyl and allyl isothiocyanates and benzyl-isoform specific metabolites in the urinary bladder after a single intravesical application to rats.
Hirose, M; Masutomi, N; Niho, N; Shibutani, M; Takahashi, N; Toyoda, K; Uneyama, C,
)
0.43
"62 µg cm(-2)) was the most toxic compound, followed by 4-chlorophenyl, 3-bromophenyl, 3,5-bis(trifluoromethyl)phenyl, cyclohexyl, 2-chlorophenyl, 4-bromophenyl and 2-bromophenyl isothiocyanates (0."( Contact and fumigant toxicity of Armoracia rusticana essential oil, allyl isothiocyanate and related compounds to Dermatophagoides farinae.
Ahn, YJ; Hwang, K; Kim, HK; Kim, JR; Yun, YK, 2012
)
0.61
"In the light of global efforts to reduce the level of highly toxic synthetic acaricides in indoor environments, the horseradish oil-derived compounds and the isothiocyanates described herein merit further study as potential acaricides for the control of house dust mite populations as fumigants with contact action."( Contact and fumigant toxicity of Armoracia rusticana essential oil, allyl isothiocyanate and related compounds to Dermatophagoides farinae.
Ahn, YJ; Hwang, K; Kim, HK; Kim, JR; Yun, YK, 2012
)
0.61
" Nevertheless, the cardiotoxicity adverse effect restricts its clinical benefit."( Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity.
Matouk, AI; Waz, S, 2022
)
1.02

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic analysis showed a rapid uptake and complete metabolism of AITC following oral administration to rats."( Pharmacokinetics, Tissue Distribution, and Anti-Lipogenic/Adipogenic Effects of Allyl-Isothiocyanate Metabolites.
Ahn, J; Chung, WJ; Ha, TY; Jang, YJ; Jung, CH; Kim, YJ; Lee, DH; Moon, JH; Seong, KS, 2015
)
0.42
" The pharmacokinetic (PK) profile and pharmacodynamic (PD) effects of GDC-0334 were evaluated in this first-in-human (FIH) study."( Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor.
Bauer, RN; Belloni, P; Chan, P; Chen, L; Ding, HT; Gao, SS; Joseph, V; Liederer, BM; Lin, JS; Mao, J; Mitra, MS; Pan, L; Putnam, WS; Quartino, A; Yang, X, 2021
)
0.62

Compound-Compound Interactions

ExcerptReferenceRelevance
"The aim of this study was to investigate the protective effect of isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine (NDBA) or N-nitrosopiperidine (NPIP)-induced oxidative DNA damage in the single cell gel electrophoresis (SCGE)/HepG2 assay."( Protective effects of isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine or N-nitrosopiperidine-induced oxidative DNA damage in the single-cell gel electrophoresis (SCGE)/HepG2 assay.
Arranz, N; García, A; Haza, AI; Morales, P; Rafter, J, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" Bioavailability of AITC is extremely high, as nearly 90% of orally administered AITC is absorbed."( Allyl isothiocyanate as a cancer chemopreventive phytochemical.
Zhang, Y, 2010
)
1.8
" Due to its high bioavailability in urine after ingestion, AITC has been considered a promising antineoplastic agent against bladder cancer."( Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil).
da Silva, GN; de Camargo, EA; Salvadori, DM; Savio, AL, 2014
)
0.61
"This study investigates the reduction of zearalenone (ZEA) and α-zearalenol (α-ZOL) on a solution model using allyl isothiocyanate (AITC) and also determines the bioaccessibility and bioavailability of the reaction products isolated and identified by MS-LIT."( Reaction of zearalenone and α-zearalenol with allyl isothiocyanate, characterization of reaction products, their bioaccessibility and bioavailability in vitro.
Bordin, K; Fernández-Blanco, C; Fernández-Franzón, M; Luciano, FB; Mañes, J; Meca, G; Ruiz, MJ; Saladino, F, 2017
)
0.93
" For example, a reaction of ITC with nucleophilic amino acid side chains of proteins such as cysteine and lysine can occur, reducing the bioavailability of indispensable amino acids and protein functions may be altered."( Determination of isothiocyanate-protein conjugates in milk and curd after adding garden cress (Lepidium sativum L.).
Hanschen, FS; Kühn, C; Rohn, S; von Oesen, T, 2018
)
0.48
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" Human PK analyses revealed that bioavailability, absorption rate constant, and lag time increase when GDC-0334 was administered with food."( Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor.
Bauer, RN; Belloni, P; Chan, P; Chen, L; Ding, HT; Gao, SS; Joseph, V; Liederer, BM; Lin, JS; Mao, J; Mitra, MS; Pan, L; Putnam, WS; Quartino, A; Yang, X, 2021
)
0.62
" Their active therapeutic relevance was hindered by a number of factors, including instability under typical physiological conditions and low bioavailability due to low aqueous solubility."( Chemopreventive aspects, investigational anticancer applications and current perspectives on allyl isothiocyanate (AITC): a review.
Patel, JK; Patil, PB, 2023
)
1.13

Dosage Studied

ExcerptRelevanceReference
" Male Fischer rats, ages 3, 16, and 27 months, were dosed orally with 14C-AITC (25 mg/kg)."( Age-related changes in the metabolism and excretion of allyl isothiocyanate. A model compound for glutathione conjugation.
Birnbaum, LS; Borghoff, SJ,
)
0.38
" The highest dosage level caused a decrease in body weight, thymus weight, blood glucose and serum globulin levels."( Short-term toxicity study of allyl isothiocyanate in rats.
Bleyl, DW; Lewerenz, HJ; Macholz, R; Plass, R, 1988
)
0.57
" Examination of the urinary bladders of male and female rats following oral dosing with [14C]AITC showed a sex difference with greater amounts of [14C]AITC and/or its metabolites within the bladder tissue of male rats."( The disposition of allyl isothiocyanate in the rat and mouse.
Bollard, M; Caldwell, J; Mitchell, S; Stribbling, S,
)
0.46
" Gnotobiotic rats harbouring the bacterial strain were orally dosed with 50 micromol sinigrin."( Formation of allyl isothiocyanate from sinigrin in the digestive tract of rats monoassociated with a human colonic strain of Bacteroides thetaiotaomicron.
Duguay, A; Elfoul, L; Khelifa, N; Quinsac, A; Rabot, S; Rimbault, A, 2001
)
0.68
" The activities of cytochrome c oxidase, AChE, and CAT were remarkably induced at a low AITC dosage (0."( Effect of allyl isothiocyanate on ultra-structure and the activities of four enzymes in adult Sitophilus zeamais.
Feng, JT; Liu, XR; Wu, H; Yu, DD; Zhang, X, 2014
)
0.8
" Its dose-response as an algogenic, sensitizing irritant remains to be elucidated in human skin."( Dose-response study of topical allyl isothiocyanate (mustard oil) as a human surrogate model of pain, hyperalgesia, and neurogenic inflammation.
Andersen, HH; Arendt-Nielsen, L; Gazerani, P; Lo Vecchio, S, 2017
)
0.74
" Pure AITC in a solution with methanol resulted in a sigmoid dose-response curve for both Fusarium spp."( Uncovering the biofumigant capacity of allyl isothiocyanate from several Brassicaceae crops against Fusarium pathogens in maize.
Audenaert, K; De Visschere, K; Deconinck, S; Haesaert, G; Leenknecht, D; Vandicke, J; Vermeir, P, 2020
)
0.83
" Human PK and PK-PD of GDC-0334 were characterized after single and multiple oral dosing using a population modeling approach."( Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor.
Bauer, RN; Belloni, P; Chan, P; Chen, L; Ding, HT; Gao, SS; Joseph, V; Liederer, BM; Lin, JS; Mao, J; Mitra, MS; Pan, L; Putnam, WS; Quartino, A; Yang, X, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
lachrymatorAny substance that stimulates the corneal nerves in the eves to cause tears.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
isothiocyanateAn organosulfur compound with the general formula R-N=C=S.
alkenyl isothiocyanate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (38)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency36.38830.002541.796015,848.9004AID1347398
AR proteinHomo sapiens (human)Potency50.66360.000221.22318,912.5098AID1259243; AID1259247; AID743042; AID743054
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
progesterone receptorHomo sapiens (human)Potency27.91810.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency35.14680.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency66.31390.001530.607315,848.9004AID1224841; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency3.98110.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency55.70390.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency7.16450.000229.305416,493.5996AID743069
aryl hydrocarbon receptorHomo sapiens (human)Potency35.14680.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency49.64610.001723.839378.1014AID743083
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency24.88200.000627.21521,122.0200AID743202
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency39.81070.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Macrophage migration inhibitory factorHomo sapiens (human)IC50 (µMol)0.67500.03803.09109.8000AID1198787; AID1198788
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)IC50 (µMol)85.90000.45003.42437.5000AID1191869
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)7.78700.00033.166210.0000AID1066633; AID1235910; AID1549771; AID1625339; AID1659750; AID329099; AID482142; AID516893; AID516896; AID516897; AID516898; AID516899; AID613621
Tyrosine-protein kinase JAK1Homo sapiens (human)EC50 (µMol)8.12000.02401.66988.1200AID1659750
Non-receptor tyrosine-protein kinase TYK2Homo sapiens (human)EC50 (µMol)8.12000.00502.93178.1200AID1659750
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)EC50 (µMol)3.43770.06002.22238.4000AID1191868; AID613619; AID644966
Transient receptor potential cation channel subfamily A member 1Mus musculus (house mouse)EC50 (µMol)22.00000.40002.771410.0000AID1549782
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)160.00000.00051.06746.3096AID1235912
Transient receptor potential cation channel subfamily M member 8Mus musculus (house mouse)EC50 (µMol)0.50000.50004.25008.0000AID1066633
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)Activity10.00000.09908.019810.0000AID500219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (115)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
prostaglandin biosynthetic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cytokine productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of mature B cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
inflammatory responseMacrophage migration inhibitory factorHomo sapiens (human)
cell surface receptor signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of gene expressionMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of protein kinase A signalingMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of macrophage chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
carboxylic acid metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cell migrationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of B cell proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of tumor necrosis factor productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of myeloid cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
regulation of macrophage activationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
innate immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of fibroblast proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of protein metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of prostaglandin secretion involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of myeloid leukocyte cytokine production involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
protein homotrimerizationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of arachidonic acid secretionMacrophage migration inhibitory factorHomo sapiens (human)
cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
response to antibioticTyrosine-protein kinase JAK1Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase JAK1Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATTyrosine-protein kinase JAK1Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
positive regulation of homotypic cell-cell adhesionTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-15-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-4-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-2-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-9-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-11-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
type III interferon-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
type II interferon-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
type I interferon-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-6-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
T-helper 17 cell lineage commitmentTyrosine-protein kinase JAK1Homo sapiens (human)
cellular response to virusTyrosine-protein kinase JAK1Homo sapiens (human)
interleukin-10-mediated signaling pathwayTyrosine-protein kinase JAK1Homo sapiens (human)
protein localization to cell-cell junctionTyrosine-protein kinase JAK1Homo sapiens (human)
positive regulation of protein localization to nucleusTyrosine-protein kinase JAK1Homo sapiens (human)
positive regulation of sprouting angiogenesisTyrosine-protein kinase JAK1Homo sapiens (human)
intracellular signal transductionTyrosine-protein kinase JAK1Homo sapiens (human)
tyrosine phosphorylation of STAT proteinTyrosine-protein kinase JAK1Homo sapiens (human)
cell differentiationTyrosine-protein kinase JAK1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein kinase JAK1Homo sapiens (human)
protein phosphorylationNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
immune responseNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cytokine-mediated signaling pathwayNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of type II interferon productionNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of interleukin-17 productionNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of natural killer cell proliferationNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
interleukin-12-mediated signaling pathwayNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
type III interferon-mediated signaling pathwayNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of T cell proliferationNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of NK T cell proliferationNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
type II interferon-mediated signaling pathwayNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
type I interferon-mediated signaling pathwayNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cellular response to virusNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
interleukin-10-mediated signaling pathwayNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of protein localization to nucleusNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
positive regulation of T-helper 17 type immune responseNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
intracellular signal transductionNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cell differentiationNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protease bindingMacrophage migration inhibitory factorHomo sapiens (human)
dopachrome isomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine receptor bindingMacrophage migration inhibitory factorHomo sapiens (human)
protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
chemoattractant activityMacrophage migration inhibitory factorHomo sapiens (human)
identical protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
phenylpyruvate tautomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase JAK1Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase JAK1Homo sapiens (human)
growth hormone receptor bindingTyrosine-protein kinase JAK1Homo sapiens (human)
protein bindingTyrosine-protein kinase JAK1Homo sapiens (human)
ATP bindingTyrosine-protein kinase JAK1Homo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase JAK1Homo sapiens (human)
ubiquitin protein ligase bindingTyrosine-protein kinase JAK1Homo sapiens (human)
CCR5 chemokine receptor bindingTyrosine-protein kinase JAK1Homo sapiens (human)
metal ion bindingTyrosine-protein kinase JAK1Homo sapiens (human)
protein tyrosine kinase activityNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activityNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
growth hormone receptor bindingNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
protein bindingNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
ATP bindingNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
type 1 angiotensin receptor bindingNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (26)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
extracellular regionMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
nucleoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytosolMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneMacrophage migration inhibitory factorHomo sapiens (human)
cell surfaceMacrophage migration inhibitory factorHomo sapiens (human)
vesicleMacrophage migration inhibitory factorHomo sapiens (human)
secretory granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular exosomeMacrophage migration inhibitory factorHomo sapiens (human)
ficolin-1-rich granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
cytoplasmTyrosine-protein kinase JAK1Homo sapiens (human)
plasma membraneTyrosine-protein kinase JAK1Homo sapiens (human)
cytoplasmic side of plasma membraneTyrosine-protein kinase JAK1Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneTyrosine-protein kinase JAK1Homo sapiens (human)
nucleusTyrosine-protein kinase JAK1Homo sapiens (human)
cytoplasmTyrosine-protein kinase JAK1Homo sapiens (human)
endosomeTyrosine-protein kinase JAK1Homo sapiens (human)
cytosolTyrosine-protein kinase JAK1Homo sapiens (human)
cytoskeletonTyrosine-protein kinase JAK1Homo sapiens (human)
focal adhesionTyrosine-protein kinase JAK1Homo sapiens (human)
cytosolTyrosine-protein kinase JAK1Homo sapiens (human)
plasma membraneNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cytoplasmic side of plasma membraneNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
extrinsic component of plasma membraneNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
nucleusNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cytoplasmNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cytosolNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cytoskeletonNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
plasma membraneNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
interleukin-12 receptor complexNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
extracellular exosomeNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
interleukin-23 receptor complexNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
cytosolNon-receptor tyrosine-protein kinase TYK2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (113)

Assay IDTitleYearJournalArticle
AID1105125Fungistatic activity in Sclerotinia sclerotiorum assessed as sclerotial viability measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105181Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 102 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1252697Inhibition of recombinant human SHP2 catalytic domain (246 to 527 amino acid residues) in 3,3-dimethylglutarate buffer using pNPP as substrate assessed as p-nitrophenolate release by spectrophotometric analysis in presence of reversible, site-directed inh2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1252698Reversible inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) measured for 3 hrs by gel filtration assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1252690Reversible inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) in Tris buffer assessed as inactivation constant kf2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1105127Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID516893Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as increase of intracellular calcium level by FDSS assay2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1105097In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 102 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235912Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID329107Activation of mouse TRPA1 expressed in HEK293T cells at 30 uM assessed as activation of cation conductance by electrophysiology2007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID1252702Chemical stability of the compound in 3,3-dimethylglutarate buffer containing DTPA, sodium acetate, Tween 80 at 500 uM at pH 7.0 at 30 degC incubated for 2.5 hrs prior to addition of PTP1B2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1235917Agonist activity at mouse TRPM8 expressed in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1092220Herbicidal activity against Cyperus iria at 75 g a.i./ha measured after 14 days relative to control2012Molecules (Basel, Switzerland), Oct-17, Volume: 17, Issue:10
Synthesis and herbicidal activity of substituted pyrazole isothiocyanates.
AID1252689Inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) using pNPP as substrate assessed as p-nitrophenolate release by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID500219Agonist activity at TRPA12005Nature chemical biology, Jul, Volume: 1, Issue:2
Sensing with TRP channels.
AID1625353Activation of TRPA1 in wild type mouse DRG neurons assessed as increase in calcium level at 10 uM treated after 10 uM Plumbagin pre-treatment by fura2/AM dye based plate reader analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1105147Fungitoxic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 1020 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID613619Agonist activity at rat TRPA1 channel expressed in HEK293 cells assessed as calcium influx measured at every 1 second for 60 seconds by fluorescence analysis2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.
AID329105Activation of mouse TRPA1 expressed in CHO cells assessed as increase in intracellular calcium level2007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID294765Antibacterial activity against methicillin-resistant Staphylococcus aureus 910 after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID1105095In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 204 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105246Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 1020 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1066633Agonist activity at TRPA1 isolated from human W138 cells expressed in HEK293T cells assessed as intracellular Ca2+ influx by Fluo-4 AM staining-based fluorescence analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID1191867Agonist activity at rat recombinant TRPA1 expressed in HEK293 cells assessed as Ca2+ influx by Fluo-4 dye based assay relative to 100 uM AITC2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.
AID1235915Activation of human TRPV1 expressed in TREx-HEK cells at 300 uM in presence of TRPV1 antagonist CPZ by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1474542Cytotoxicity against human LoVo/DX cells after 72 hrs by sulforhodamine B assay2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105118Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 510 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1054581Activity at recombinant human MAO-A expressed in baculovirus infected BT1 cells assessed as residual activity using benzylamine as substrate at 20 uM preincubated for 30 mins by Amplex Red assay relative to control2013European journal of medicinal chemistry, , Volume: 70Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
AID1105119Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 102 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692256Induction of p53 R280K mutant depletion in human MDA-MB-231 cells at 10 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1625343Activation of human TRPA1 expressed in HEK293 cells assessed as induction of outward current at 10 uM at -70 to +70 mV by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID516899Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as time point of maximal current amplitude by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1105247Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 714 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1198787Inhibition of human recombinant macrophage migration inhibitory factor tautomerase activity expressed in Escherichia coli DH5alpha using L-dopachrome methyl ester as substrate incubated for 5 mins prior to substrate addition measured for 2 mins by spectro2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID1092216Herbicidal activity against Trifolium repens at 75 g a.i./ha measured after 14 days relative to control2012Molecules (Basel, Switzerland), Oct-17, Volume: 17, Issue:10
Synthesis and herbicidal activity of substituted pyrazole isothiocyanates.
AID1105178Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 1022 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235904Activation of human TRPA1 expressed in TREx-HEK cells at 1 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID516896Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells at -75 mV holding potential by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1105153Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 714 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105214Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2043 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID294759Antibacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID1235914Activation of human TRPV1 expressed in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1549771Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1549813Agonist activity at human TRPA1 Phe909Ala mutant expressed in HEK293 cells assessed as Ca2+ influx at 10 uM by fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1252692Reversible inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) in 3,3-dimethylglutarate buffer assessed as inactivation constant kf2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1625342Activation of human TRPA1 expressed in HEK293 cells assessed as induction of inward current at 10 uM at -70 to +70 mV by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1092218Herbicidal activity against Dactylis glomerata at 75 g a.i./ha measured after 14 days relative to control2012Molecules (Basel, Switzerland), Oct-17, Volume: 17, Issue:10
Synthesis and herbicidal activity of substituted pyrazole isothiocyanates.
AID1105180Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 307 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1252691Inhibition of recombinant human SHP2 catalytic domain (246 to 527 amino acid residues) in 3,3-dimethylglutarate buffer using pNPP as substrate assessed as apparent second order rate constant after 10 mins2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID613621Agonist activity at human TRPA1 channel expressed in HEK293 cells assessed as calcium influx measured at every 1 second for 60 seconds by fluorescence analysis2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.
AID1252705Reversible inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) in 3,3-dimethylglutarate buffer assessed as inactivation constant kr2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1625339Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level by fluo-4 dye based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID294760Antibacterial activity against Mycobacterium avium 724S after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID1054579Ratio of residual Vmax to Km for recombinant human MAO-A expressed in baculovirus infected BT1 cells assessed as residual activity using benzylamine as substrate at 20 uM preincubated for 30 mins by Amplex Red assay2013European journal of medicinal chemistry, , Volume: 70Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
AID1235911Activation of human TRPA1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay relative to 100 uM ITC2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID482142Activation of TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1659750Agonist activity at TRPA1 (unknown origin)2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
AID1105117Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 1020 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID644965Agonist activity at rat TRPA1 ion channel expressed in HEK293 cells assessed as calcium influx by fluo-4-Am-based fluorimetry relative to ionomycin2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
AID1252694Inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) using pNPP as substrate assessed as p-nitrophenolate release after 10 mins by spectrophotometric analysis in presence of catalase, superoxide dismutase and mannitol2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID329099Activation of TRPA12007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID1252696Inhibition of recombinant human SHP2 catalytic domain (246 to 527 amino acid residues) in 3,3-dimethylglutarate buffer using pNPP as substrate assessed as p-nitrophenolate release by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1625341Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level at 20 uM by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID294764Antibacterial activity against methicillin-resistant Staphylococcus aureus 908 after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID644966Agonist activity at rat TRPA1 ion channel expressed in HEK293 cells assessed as calcium influx by fluo-4-Am-based fluorimetry2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
AID1105216Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 920 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID516897Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells at -30 mV holding potential by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID692257Induction of covalent cysteine modification at p53 G245C mutant in human NCI-H596 cells at 100 uM incubated for 1 hr by monochlorobimane fluorometric assay2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID294763Antibacterial activity against methicillin-resistant Staphylococcus aureus 906 after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID1105217Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 715 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1549804Agonist activity at human TRPA1 Cys261Ala mutant expressed in HEK293 cells assessed as Ca2+ influx at 10 uM by fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID692255Induction of p53 G245C mutant depletion in human NCI-H596 cells at 20 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105179Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 511 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID516898Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells at 75 mV holding potential by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1252695Inhibition of recombinant human SHP2 catalytic domain (246 to 527 amino acid residues) in Tris buffer using pNPP as substrate assessed as apparent second order rate constant after 10 mins2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1105126Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1191868Agonist activity at rat recombinant TRPA1 expressed in HEK293 cells assessed as Ca2+ influx by Fluo-4 dye based assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.
AID1105120Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 51 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1252700Reversible inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) in Tris buffer assessed as inactivation constant kr2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1105249Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 102 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1252693Inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) using pNPP as substrate assessed as p-nitrophenolate release at 200 uM after 10 mins by spectrophotometric analysis in presence of reversible, site-directed inhibitor ph2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1235908Effect on Ca2+ response in TREx-HEK cells at 1 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1191869Antagonist activity against rat recombinant TRPA1 expressed in HEK293 cells assessed as inhibition of AITC-induced Ca2+ influx pre-treated 5 mins before capsaicin addition by Fluo-4 dye based assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.
AID1467696Activation of TRPA1 in Sprague-Dawley rat DRG neuron assessed as induction of current response at -60 mV holding potential at 300 uM incubated for 30 secs by whole-cell patch-clamp assay2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID1474541Cytotoxicity against human LoVo cells after 72 hrs by sulforhodamine B assay2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1833098Agonist activity at human TRPA1 expressed in HEK293 cells assessed as induction of Ca2+ influx at 300 uM measured under 365 nm UV irradiation by Fluo-8 based calcium imaging assay2021Journal of medicinal chemistry, 11-11, Volume: 64, Issue:21
Photosensitive and Photoswitchable TRPA1 Agonists Optically Control Pain through Channel Desensitization.
AID1235916Effect on Ca2+ response in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1105215Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1022 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1625336Increase in calcium level in DRG neurons isolated from TRPA1 deficient mouse at 10 uM by fura2/AM dye based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID692164Induction of p53 G245C mutant depletion in human NCI-H596 cells at 40 uM incubated for 2 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID294762Antibacterial activity against methicillin-resistant Staphylococcus aureus 873 after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID294761Antibacterial activity against Staphylococcus aureus after 2 weeks by broth dilution method2007Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
AID1235910Activation of human TRPA1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1235906Activation of human TRPA1 expressed in TREx-HEK cells at 1 uM in presence of TRPA1 antagonist HC030031 by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1252701Chemical stability of the compound in Bis-Tris and Tris buffer containing DTPA, sodium acetate, Tween 80 at 500 uM at pH 7.0 at 30 degC incubated for 2.5 hrs prior to addition of PTP1B2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1198788Inhibition of macrophage migration inhibitory factor tautomerase activity in human Jurkat T cells using L-dopachrome methyl ester as substrate incubated for 30 mins prior to substrate addition measured for 2 mins by spectrophotometric analysis2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID1054580Activity at recombinant human MAO-B expressed in baculovirus infected BT1 cells assessed as residual activity using benzylamine as substrate at 20 uM preincubated for 30 mins by Amplex Red assay relative to control2013European journal of medicinal chemistry, , Volume: 70Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
AID1105143Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 3065 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235913Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay relative to 10 uM capsaicin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1252699Inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) using pNPP as substrate assessed as p-nitrophenolate release at 500 uM incubated with first aliquot of enzyme for 2000 secs followed by addition of second aliquot of enz2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1105182Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 51 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105248Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 510 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1054578Ratio of residual Vmax to Km for recombinant human MAO-B expressed in baculovirus infected BT1 cells assessed as residual activity using benzylamine as substrate at 20 uM preincubated for 30 mins by Amplex Red assay2013European journal of medicinal chemistry, , Volume: 70Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
AID1105250Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 51 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1549782Agonist activity at mouse TRPA1 expressed in CHO cells assessed as increase in calcium influx by Fluo-3 based FLIPR analysis2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1092222Herbicidal activity against Echinochloa crus-galli (barnyard grass) at 75 g a.i./ha measured after 14 days relative to control2012Molecules (Basel, Switzerland), Oct-17, Volume: 17, Issue:10
Synthesis and herbicidal activity of substituted pyrazole isothiocyanates.
AID1105213Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 3065 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1346567Mouse TRPA1 (Transient Receptor Potential channels)2004Neuron, Mar-25, Volume: 41, Issue:6
Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin.
AID1346640Rat TRPA1 (Transient Receptor Potential channels)2004Nature, Jan-15, Volume: 427, Issue:6971
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (482)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (4.98)18.7374
1990's21 (4.36)18.2507
2000's101 (20.95)29.6817
2010's255 (52.90)24.3611
2020's81 (16.80)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 61.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index61.56 (24.57)
Research Supply Index6.23 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index103.33 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (61.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (1.40%)5.53%
Reviews7 (1.40%)6.00%
Case Studies1 (0.20%)4.05%
Observational0 (0.00%)0.25%
Other485 (97.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]